Neurol. praxi. 2020;21(5):369-371 | DOI: 10.36290/neu.2020.114

Pain in multiple sclerosis patients

MUDr. Marta Vachová
Neurologické oddělení s RS centrem, Nemocnice Teplice, o. z. - Krajská zdravotní, a. s., Teplice
Neurologická klinika VFN, Praha

Pain belongs among the most disabling clinical symptoms of multiple sclerosis. Most frequent is chronic central neuropathic type of that. The best treatment option is anticonvulsants therapy by gabanoids or tricyclic antidepressants, but often the second or third line therapy have to been used. One of these next line therapies are the cannabinoids now. Managing of pain treatment needs the multidisciplinary team, including physio and psychotherapeutics. Other type of pain is neuromuscular due to changed movement stereotypes. The primary headaches, like migraine or tension type, occurred frequently.

Keywords: neuropathic pain, multiple sclerosis, anticonvulsants, tricyclic antidepressants, cannabinoids, multidisplinary team, neuromuscular pain.

Published: November 11, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vachová M. Pain in multiple sclerosis patients. Neurol. praxi. 2020;21(5):369-371. doi: 10.36290/neu.2020.114.
Download citation

References

  1. Bednařík J, Ambler Z, Opavský J, Keller O, Rokyta R, Mazanec R, Lejčko J, Kozák J, Suchý M, Pátá M, Kožený P. Klinický standard pro farmakoterapii neuropatické bolesti. Česk Slov Neurol N 2012; 75/108(1): 93-101.
  2. Ferraro D, Plantone D, Morselli F, Dallari G, Simone AM, Vitetta F, Sola P, Primiano G, Nociti V, Pardini M, Mirabella M, Vollono C. Systematic assessment and characterization of chronic pain in multiple sclerosis patients. Neurological Sciences 2018; 39: 445-453. Go to original source... Go to PubMed...
  3. Hakl M (ed.). Léčba bolesti. Současné přístupy k léčbě bolesti a bolestivých syndromů. 3. přepracované a doplněné vydání. Mladá fronta 2019. ISBN 978-80-204-5272-6.
  4. Havrdová E, a kol. Roztroušená skleróza. Mladá fronta 2013. ISBN 978-80-204-3154-7.
  5. Langford RM, Mares J, Novotna A, Vachova M, Novakova I, Notcutt W, Ratcliffe S. A double-blind, randomized, placebo-controlled, parallalel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. J Neurol 2013; 260: 984-997. doi 10.1007/s00415-012-6739-4. Go to original source... Go to PubMed...
  6. Mathieu D, Effendi K, Blanchard J, Séguin M. Comparative study of Gamma Knife surgery and peercutaneous retrogasserian glycerol rhizotomy for trigeminal neuralgie in patientrs with multiple sclerosis. J Neurosurg 2012; 117(suppl): 175-180. Go to original source... Go to PubMed...
  7. Štětkářová (ed.). Moderní farmakoterapie v neurologii. 2. rozšířené vydání. Maxdorf 2017. ISBN 978-80-7345-529-3.
  8. Torres-Moreno MC, Papaseit E, Torrens M, Farré M. Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis. JAMA Netw Open 2018; 1(6): e183485. Go to original source... Go to PubMed...
  9. https.uptodate.com/contens/trigeminal-neuralgia.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.